Xuan G. Luong

Xuan G. Luong

Auto-generated profile, based on publicly available information

Xuan G. Luong

Center for Reproductive Sciences, University of California, San Francisco, CA 94143, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
XLXuan G Luong
Xuan G Luong
EDenrico maria daldello
enrico maria daldello
GRGabriel Rajkovic
Gabriel Rajkovic
CYCai-Rong Yang
Cai-Rong Yang
MCMarco Conti
Marco Conti
During oocyte maturation, changes in gene expression depend exclusively on translation and degradation of maternal mRNAs rather than transcription. Execution of this translation program is essential for assembling the molecular machinery required for meiotic progression, fertilization, and embryo development. With the present study, we used a RiboTag/RNA-Seq approach to explore the timing of maternal mRNA translation in quiescent oocytes as well as in oocytes progressing through the first meiotic division. This genome-wide analysis reveals a global switch in maternal mRNA translation coinciding with oocyte re-entry into the meiotic cell cycle. Messenger RNAs whose translation is highly active in quiescent oocytes invariably become repressed during meiotic re-entry, whereas transcripts repressed in quiescent oocytes become activated. Experimentally, we have defined the exact timing of the switch and the repressive function of CPE elements, and identified a novel role for CPEB1 in maintaining constitutive translation of a large group of maternal mRNAs during maturation.

11 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXuan G. Luong
Xuan G. Luong
SSSarah K. Stevens
Sarah K. Stevens
AJAndreas Jekle
Andreas Jekle
TLTse-I Lin
Tse-I Lin
KGKusum Gupta
Kusum Gupta
JDJerome Deval
Jerome Deval
Thyroid hormones are important modulators of metabolic activity in mammals and alter cholesterol and fatty acid levels through activation of the nuclear thyroid hormone receptor (THR). Currently, there are several THRβ agonists in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) that have demonstrated the potential to reduce liver fat and restore liver function. In this study, we tested three THRβ-agonism-based NASH treatment candidates, GC-1 (sobetirome), MGL-3196 (resmetirom), and VK2809, and compared their selectivity for THRβ and their ability to modulate the expression of genes specific to cholesterol and fatty acid biosynthesis and metabolismin vitrousing human hepatic cells andin vivousing a rat model. Treatment with GC-1 upregulated the transcription ofCPT1Ain the human hepatocyte-derived Huh-7 cell line with a dose-response comparable to that of the native THR ligand, triiodothyronine (T3). VK2809A (active parent of VK2809), MGL-3196, and VK2809 were approximately 30-fold, 1,000-fold, and 2,000-fold less potent than T3, respectively. Additionally, these relative potencies were confirmed by quantification of other direct gene targets of THR, namely,ANGPTL4andDIO1. In primary human hepatocytes, potencies were conserved for every compound except for VK2809, which showed significantly increased potency that was comparable to that of its active counterpart, VK2809A. In high-fat diet fed rats, a single dose of T3 significantly reduced total cholesterol levels and concurrently increased liverDio1andMe1RNA expression. MGL-3196 treatment resulted in concentration-dependent decreases in total and low-density lipoprotein cholesterol with corresponding increases in liver gene expression, but the compound was significantly less potent than T3. In conclusion, we have implemented a strategy to rank the efficacy of THRβ agonists by quantifying changes in the transcription of genes that lead to metabolic alterations, an effect that is directly downstream of THR binding and activation.

1 November 2015 in Aquatic Toxicology
Verified
Journal Article
Closed access
RPRikke Poulsen
Rikke Poulsen
XLXuan Luong
Xuan Luong
MHMartin Hansen
Martin Hansen
BSBjarne Styrishave
Bjarne Styrishave
THTyrone Hayes
Tyrone Hayes

1 January 2019 in Development
Verified
Journal Article
Open access
PDF file
EDenrico maria daldello
enrico maria daldello
XLXuan G. Luong
Xuan G. Luong
CYCai-Rong Yang
Cai-Rong Yang
JKJonathan Kuhn
Jonathan Kuhn
MCMarco Conti
Marco Conti
Cyclins associate with cyclin-dependent serine/threonine kinase 1 (CDK1) to generate the M phase-promoting factor (MPF) activity essential for progression through mitosis and meiosis. Although cyclin B1 (CCNB1) is required for embryo development, previous studies concluded that CCNB2 is dispensable for cell cycle progression. Given previous findings of high Ccnb2 mRNA translation rates in prophase-arrested oocytes, we re-evaluated the role of this cyclin during meiosis. Ccnb2−/− oocytes underwent delayed germinal vesicle breakdown and showed defects during the metaphase-to-anaphase transition. This defective maturation was associated with compromised Ccnb1 and Moloney sarcoma oncogene (Mos) mRNA translation, delayed spindle assembly and increased errors in chromosome segregation. Given these defects, a significant percentage of oocytes failed to complete meiosis I because the spindle assembly checkpoint remained active and anaphase-promoting complex/cyclosome function was inhibited. In vivo, CCNB2 depletion caused ovulation of immature oocytes, premature ovarian failure, and compromised female fecundity. These findings demonstrate that CCNB2 is required to assemble sufficient pre-MPF for timely meiosis re-entry and progression. Although endogenous cyclins cannot compensate, overexpression of CCNB1/2 rescues the meiotic phenotypes, indicating similar molecular properties but divergent modes of regulation of these cyclins.

23 May 2016 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MHMartin Hansen
Martin Hansen
XLXuan Luong
Xuan Luong
DSDavid L. Sedlak
David L. Sedlak
CHCaren Helbing
Caren Helbing
THTyrone Hayes
Tyrone Hayes

3 October 2014 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MHMartin Hansen
Martin Hansen
RPRikke Poulsen
Rikke Poulsen
XLXuan Luong
Xuan Luong
DSDavid L. Sedlak
David L. Sedlak
THTyrone Hayes
Tyrone Hayes